David O. Chang

Associate

David Chang’s practice focuses on complex civil litigation in state and federal courts.  David has represented clients in the pharmaceutical, medical device, aerospace, financial services, food manufacturing, and mobile advertising industries. He handles all stages of pretrial litigation, including initial fact gathering, briefing dispositive motions, managing discovery, and depositions.

David maintains an active pro bono practice representing clients in asylum and citizenship matters.

Prior to joining Coblentz, David was an associate at Reed Smith LLP. Before law school, he worked as a pharmaceutical sales representative with GlaxoSmithKline and a leadership development program associate with Wells Fargo.

David is a member of the Bar Association of San Francisco, the Asian American Bar Association of the Greater Bay Area, and the National Asian Pacific American Bar Association.

David earned his J.D. from the University of California, Hastings College of the Law, where he was Development Editor of the Hastings Law Journal, Co-Chair of the Moot Court Board, and Associated Students of UC Hastings 1L Representative. David’s Hastings Law Journal note “Internalizing the External Costs of Medical Device Preemption” was cited by Judge Neil Gorsuch of the United States Court of Appeals, Tenth Circuit in Caplinger v. Medtronic, Inc., 784 F.3d 1335, 1338 (10th Cir. 2015). David also participated in the Hastings Appellate Project where he argued in front of the United States Court of Appeals, Ninth Circuit in Yuanku Li v. Holder, 570 Fed. Appx. 660 (9th Cir. 2014).

David earned his Master of Business Administration, with honors, from the Thunderbird School of Global Management, where he was class president as well as a member of the Beta Gamma Sigma Honor Society and the Pi Sigma Alpha Honor Society. David earned his B.S. in Business Administration with a minor in Marketing from Pepperdine University, where he was class president and National Student Director for the Sigma Phi Epsilon fraternity.